This year we are celebrating 25 years of smarter studies, global impact, and better health. '25 at 25' is a series of articles highlighting 25 of our major achievements.
Latest News
Hormone therapy can delay prostate cancer spread in people who had surgery and radiotherapy
Findings from the RADICALS-HD study confirm that adding two years, compared to six months, of hormone therapy delays prostate cancer spread in people who had surgery to remove the prostate followed by radiotherapy.
17 May
Men who have had prostate cancer surgery do not need immediate radiotherapy
Longer follow-up from RADICALS-RT confirms that having radiotherapy only if the cancer returns, as opposed to having it soon after surgery, is a better approach for most people.
17 May
'25 at 25': Transforming treatment for gastroesophageal cancer
Our '25 at 25' series shines the spotlight on our OE02 and MAGIC trials, which showed how pre- and peri-operative chemotherapy can help people with stomach and oesophageal cancer live longer.
10 May
Mahesh Parmar awarded Royal Statistical Society’s 2024 Bradford Hill Medal
Professor Mahesh Parmar has been recognised for his outstanding contributions to the field of medical statistics, including his work on innovative designs for late-phase clinical trials.
08 May
Research Themes
Cancer
Innovative clinical trial design and meta-analysis extending beyond the boundaries of single cancer types
Infections
Major international clinical trials answering questions of global public health significance
Neurodegenerative diseases
New generation of innovative multi-arm multi-stage trials to identify and test new therapeutic treatments in neurodegenerative diseases (NDD)
Methodology
Development of methods with direct impact on the design, conduct and analysis of studies
Other Research & Policy
This section will capture projects outside the current QQR themes